CLINICAL Self-monitoring of Blood Glucose in Type 2 Diabetes: Cost-effectiveness in the United States
March 01, 2008
By Sandra L. Tunis, PhD
For patients with type 2 diabetes taking oral antidiabetics, self-monitoring of blood glucose cost-effectiveness (1 and 3 times per day) was modeled. Both strategies represented good value in the US payer setting.